Prevalence of Anemia and Its Associated Factors Among Chronic Kidney Disease Patients Attending Selected Public Hospitals of Addis Ababa, Ethiopia: Institutional-Based Cross-Sectional Study.
Ethiopia
anemia
chronic kidney disease
prevalence
Journal
International journal of nephrology and renovascular disease
ISSN: 1178-7058
Titre abrégé: Int J Nephrol Renovasc Dis
Pays: New Zealand
ID NLM: 101550217
Informations de publication
Date de publication:
2021
2021
Historique:
received:
18
12
2020
accepted:
20
02
2021
entrez:
12
3
2021
pubmed:
13
3
2021
medline:
13
3
2021
Statut:
epublish
Résumé
Anemia is a global public health problem with high mortality and morbidity. It is becoming more prevalent in Ethiopia. Therefore, this study aimed to estimate the prevalence of anemia and its associated factors among chronic kidney disease patients at selected public hospitals of Addis Ababa, Ethiopia. An institutional-based cross-sectional study was conducted on selected public hospitals in Addis Ababa for studies on anemia in CKD patients. Data was entered into EPI Info version 4.4.1 and exported to SPSS version 24 for analysis. Both bivariate and multivariate logistic regression analyses were used to identify independently associated factors of anemia in CKD patients. Multivariate analysis was used to control the possible effect of confounders. A total of 387 participants were included to estimate the prevalence of anemia among chronic kidney disease patients. The prevalence of anemia was 53.5% (95% CI). Being females were 2 times more likely to develop anemia as compared to their counterparts (AOR=2.04, 95%:1.18, 2.46) and hemodialysis history had two times higher odds for anemia (AOR=2.754, 95% CI: 1.218-6.229, P=0.015) compared to patients without hemodialysis history. The overall prevalence of anemia across all stages of CKD is 53.5%. From the stage of CKD, stage 5 CKD has a higher (90.9%) anemia prevalence compared to others, and females showed a higher frequency of anemia when compared with males. Therefore, situation-based interventions and country context-specific preventive strategies should be developed to reduce the prevalence of anemia in this patient group.
Sections du résumé
BACKGROUND
BACKGROUND
Anemia is a global public health problem with high mortality and morbidity. It is becoming more prevalent in Ethiopia. Therefore, this study aimed to estimate the prevalence of anemia and its associated factors among chronic kidney disease patients at selected public hospitals of Addis Ababa, Ethiopia.
METHODS
METHODS
An institutional-based cross-sectional study was conducted on selected public hospitals in Addis Ababa for studies on anemia in CKD patients. Data was entered into EPI Info version 4.4.1 and exported to SPSS version 24 for analysis. Both bivariate and multivariate logistic regression analyses were used to identify independently associated factors of anemia in CKD patients. Multivariate analysis was used to control the possible effect of confounders.
RESULTS
RESULTS
A total of 387 participants were included to estimate the prevalence of anemia among chronic kidney disease patients. The prevalence of anemia was 53.5% (95% CI). Being females were 2 times more likely to develop anemia as compared to their counterparts (AOR=2.04, 95%:1.18, 2.46) and hemodialysis history had two times higher odds for anemia (AOR=2.754, 95% CI: 1.218-6.229, P=0.015) compared to patients without hemodialysis history.
CONCLUSION
CONCLUSIONS
The overall prevalence of anemia across all stages of CKD is 53.5%. From the stage of CKD, stage 5 CKD has a higher (90.9%) anemia prevalence compared to others, and females showed a higher frequency of anemia when compared with males. Therefore, situation-based interventions and country context-specific preventive strategies should be developed to reduce the prevalence of anemia in this patient group.
Identifiants
pubmed: 33707966
doi: 10.2147/IJNRD.S296995
pii: 296995
pmc: PMC7943544
doi:
Types de publication
Journal Article
Langues
eng
Pagination
67-75Informations de copyright
© 2021 Alemu et al.
Déclaration de conflit d'intérêts
The authors declare that they have no competing interests.
Références
Lancet. 2004 Jan 10;363(9403):157-63
pubmed: 14726171
Kidney Int Suppl (2011). 2013 Jan;3(1):19-62
pubmed: 25018975
PLoS One. 2019 Apr 25;14(4):e0215920
pubmed: 31022266
PLoS One. 2019 Sep 9;14(9):e0222111
pubmed: 31498832
Nefrologia (Engl Ed). 2018 Jan - Feb;38(1):8-12
pubmed: 29128260
PLoS One. 2014 Jan 02;9(1):e84943
pubmed: 24392162
Kidney Int. 2013 Sep;84(3):622-3
pubmed: 23989362
Kidney Int. 2005 Jun;67(6):2089-100
pubmed: 15882252
Int J Nephrol Renovasc Dis. 2019 Oct 15;12:219-228
pubmed: 31686891
World J Nephrol. 2016 Jul 6;5(4):358-66
pubmed: 27458564
J Korean Med Sci. 2017 Feb;32(2):221-230
pubmed: 28049232